Tower Research Capital LLC (Trc) Pulmonx Corp Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Pulmonx Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 7,552 shares of LUNG stock, worth $62,606. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,552
Previous 668
1030.54%
Holding current value
$62,606
Previous $6,000
683.33%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding LUNG
# of Institutions
116Shares Held
30.6MCall Options Held
400Put Options Held
0-
Primecap Management CO Pasadena, CA5.71MShares$47.3 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.47MShares$28.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$22.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$18 Million0.0% of portfolio
-
Deutsche Bank Ag\ Frankfurt Am Main, 2M1.29MShares$10.7 Million0.0% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $309M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...